Detalhe da pesquisa
1.
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
Cancer
; 127(9): 1425-1431, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721334
2.
Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities.
J Urol
; 206(6): 1403-1410, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288719
3.
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
J Urol
; 205(3): 732-739, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080150
4.
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
J Urol
; 204(4): 748-753, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259468
5.
Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.
BJU Int
; 126(3): 373-378, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367635
6.
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
Cancer
; 125(3): 391-397, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423193
7.
Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time.
J Urol
; 211(2): 317-319, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010955
9.
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.
J Urol
; 201(1): 98-104, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30114397
10.
Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
J Urol
; 201(5): 937-942, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30414957
11.
Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?
BJU Int
; 124(2): 282-289, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653804
12.
Tissue-based genomics: which test and when.
Curr Opin Urol
; 29(6): 598-604, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584886
13.
A Pragmatic Approach to Prostate Cancer Screening.
JAMA
; 331(17): 1448-1450, 2024 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581253
14.
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.
Mod Pathol
; 31(10): 1539-1552, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849114
15.
Point-Counterpoint: Clinical Pragmatism Should Prevail Over Biological Orthodoxy: "Pro" Perspective.
J Urol
; 210(1): 26-27, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126312
16.
National Trends in the Practice of Active Surveillance.
J Urol
; 209(4): 659-660, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36756801
17.
Editorial Comment.
J Urol
; 210(1): 106-107, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102722
18.
Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.
J Urol
; 199(4): 954-960, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074222
19.
Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.
J Urol
; 200(5): 1068-1074, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29673946
20.
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
BJU Int
; 121(4): 619-626, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232037